Autoimmunité And NotEmanuela Martinuzzi

List of bibliographic references

Number of relevant bibliographic references: 13.

Ident.	Authors (with country if any)	Title
000773	Francesca Poli [Italie] ; Sebastiaan Overeem [Pays-Bas] ; Gert Jan Lammers [Pays-Bas] ; Giuseppe Plazzi [Italie] ; Michel Lecendreux [France] ; Claudio L. Bassetti [Suisse] ; Yves Dauvilliers [France] ; Daniel Keene [Canada] ; Ramin Khatami [Suisse] ; YULIN LI [Suisse] ; Geert Mayer [Allemagne] ; Hanna Nohynek [Finlande] ; Barbara Pahud [États-Unis] ; Teresa Paiva [Portugal] ; Markku Partinen [Finlande] ; Thomas E. Scammell [États-Unis] ; Tom Shimabukuro [États-Unis] ; Miriam Sturkenboom [Pays-Bas] ; Kristy Van Dinther [Australie] ; Max Wiznitzer [États-Unis] ; Jan Bonhoeffer [Suisse]	Narcolepsy as an adverse event following immunization: Case definition and guidelines for data collection, analysis and presentation
000821	David J. Kuter [États-Unis] ; James B. Bussel [États-Unis] ; Adrian Newland [Royaume-Uni] ; Ross I. Baker [Australie] ; Roger M. Lyons [États-Unis] ; Jeffrey Wasser [États-Unis] ; Jean-Francois Viallard [France] ; Gail Macik [États-Unis] ; Mathias Rummel [Allemagne] ; KUN NIE [États-Unis] ; Susie Jun [États-Unis]	Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
000876	Michael Maes [Thaïlande] ; Marta Kubera [Pologne] ; Ivana Mihaylova [Bulgarie] ; Michel Geffard [France] ; Piotr Galecki [Pologne] ; Jean-Clude Leunis [Belgique] ; Michael Berk [Australie]	Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: Implications for the pathways to chronic depression and neuroprogression
000879	Michael Maes [Thaïlande, Australie] ; Karl Ringel [Allemagne] ; Marta Kubera [Pologne] ; George Anderson [Royaume-Uni] ; Gerwyn Morris [Royaume-Uni] ; Piotr Galecki [Pologne] ; Michel Geffard [France]	In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation
000880	M. Maes [Thaïlande] ; M. Kubera [Pologne] ; J.-C. Leunis [Belgique] ; M. Berk [Australie] ; M. Geffard [France] ; E. Bosmans [Belgique]	In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes
001544	Revital Aricha [Israël] ; Tali Feferman [Israël] ; Hamish S. Scott [Australie] ; Miriam C. Souroujon [Israël] ; Sonia Berrih-Aknin [France] ; Sara Fuchs [Israël]	The susceptibility of Aire-/- mice to experimental myasthenia gravis involves alterations in regulatory T cells
002747	Kelly Tierney [France] ; Pavitra Delpachitra [France] ; Mathis Grossmann [Australie] ; Joseph Onwude [Australie] ; Ken Sikaris [Royaume-Uni] ; Euan M. Wallace [France] ; Emma J. Hamilton [Australie] ; Stephen Tong [France, Australie]	Thyroid function and autoantibody status among women who spontaneously deliver under 35 weeks of gestation
004A60	Angela Tincani [Italie] ; Flavio Allegri [Italie] ; Genesio Balestrieri [Italie] ; Guido Reber [Suisse] ; Marielle Sanmarco [France] ; Pierluigi Meroni [Italie] ; Marie-Claire Boffa [France]	Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European forum on antiphospholipid antibodies
005473	J. Arvieux [France] ; Y. Renaudineau [France] ; I. Mane [Sénégal] ; R. Perraut [Sénégal] ; S. A. Krilis [Australie] ; P. Youinou [France]	Distinguishing features of Anti-β2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome
005718	Daniel L. Kaufman [États-Unis] ; Roland Tisch [États-Unis] ; Nora Sarvetnick [États-Unis] ; Lucienne Chatenoud [France] ; Leonard C. Harrison [Australie] ; Kathryn Haskins [États-Unis] ; Anthony Quinn [États-Unis] ; Eli Sercarz [États-Unis] ; Bhagi Singh [Canada] ; Matthias Von Herrath [États-Unis] ; Dale Wegmann [États-Unis] ; LI WEN [États-Unis] ; Dan Zekzer [États-Unis]	Report from the 1st International NOD mouse T-cell workshop and the follow-up mini-workshop
005C25	B. Acres [France] ; V. Apostolopoulos [Australie] ; J.-M. Balloul [France] ; D. Wreschner [Israël] ; P.-X. Xing [Australie] ; D. Ali-Hadji [France] ; N. Bizouarne [France] ; M. P. Kieny [France] ; I. F. C. Mckenzie [Australie]	MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines
005D44	M. Sasaki [États-Unis] ; A. Ansari [États-Unis] ; N. Pumford [États-Unis] ; J. Van De Water [États-Unis] ; P. S. C. Leung [États-Unis] ; K. M. Humphries [États-Unis] ; L. I. Szweda [États-Unis] ; Y. Nakanuma [États-Unis] ; T. E. Roche [États-Unis] ; R. L. Coppel [Australie] ; J.-F. Bach [France] ; M. E. Gershwin [États-Unis]	Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in Primary biliary cirrhosis : Searching for a mimic
006470	J.-P. De Villartay [France] ; F. Rieux-Laucat [France] ; A. Fischer [France] ; F. Le Deist [France]	Clinical effects of mutations to CD95 (Fas) : relevance to autoimmunity?

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024